Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles by From the College

HHS Policy Shift Raises Questions about Future of Public Comment on Rulemaking

From the College  |  March 11, 2025

The rescindment of the Richardson Waiver in late February suggests that the HHS may move toward rulemaking without providing public notice and comment procedures.

How NIH, FDA Nominees May Affect Rheumatology

From the College  |  March 11, 2025

The nominations of Jay Bhattacharya, MD, PhD, as director of the National Institutes of Health and Martin Makary, MD, MPH, for commissioner of the Food & Drug Administration have the potential to significantly impact federally funded healthcare research, federal responses to public health emergencies and federal regulation of drugs and medical devices.

2025 Advocates for Arthritis Applications Now Open

From the College  |  March 6, 2025

This annual event, to be held May 4–6, brings together the rheumatology community to advocate on Capitol Hill for the profession and rheumatic disease patients.

Will Telehealth Make It to April? 

From the College  |  March 6, 2025

Medicare’s current telehealth flexibilities are set to expire March 31. To avoid a government shutdown, Congress must pass a  appropriations package by midnight on March 14. The ACR is preparing for the impacts if a telehealth extension does not pass.

2025 Calendar of Rheumatology Events

Joseph Cantrell, JD  |  March 1, 2025

State rheumatology society meetings and other conferences provide continuing medical education, networking and collaboration opportunities. Check this year’s calendar for rheumatology events near you.

Stay Current on Coding Guidelines with ACR Lunch-and-Learns

From the College  |  February 25, 2025

Available topics include CPT telemedicine code sets, G2211 coding updates, evolving HIPAA guidelines, evaluation and management (E/M) coding and billing strategies.

CMS to Host Town Halls on Medicare Drug Price Negotiation Program

From the College  |  February 22, 2025

These events will provide a critical opportunity for patients, caregivers, patient organizations, clinicians and researchers to offer input on the drugs selected for the second cycle of negotiations.

RheumPAC Announces New Donor Perks for 2025

From the College  |  February 22, 2025

RheumPAC contributions enable the ACR to educate key legislators and their staff about the critical issues rheumatologists and rheumatology care team members face.

How RheumPAC Is Supporting You in Uncertain Times

From the College  |  February 11, 2025

As the new administration enacts policies that impact you and the care you provide to your patients, RheumPAC is working to inform key lawmakers of the downstream effects of these unilateral actions. Learn more about RheumPAC’s role in the ACR’s advocacy efforts.

Rheumatologist Elected to Key AMA Committee That Helps CMS Set Medicare Reimbursements

Leslie Mertz, PhD  |  February 10, 2025

Luke Barré, MD, MPH, RhMSUS, has been elected to the American Medical Association’s Relative Value Update Committee. He is the second rheumatologist to hold the seat  in recent years and will ensure representation of the specialty during valuation of physician services.

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 95
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences